IPO - Global Health Solutions, Inc

Form Type: 253G2

Filing Date: 2025-04-22

Corporate Action: Ipo

Type: Update

Accession Number: 000110465925037431

Filing Summary: This filing is a supplement to the offering statement on Form 1-A filed by Global Health Solutions, Inc., which is doing business as Turn Therapeutics. The SEC qualified this offering statement on March 31, 2025, and this supplement is intended to announce a modification effective April 23, 2025, which adjusts the minimum investment required for participation in the offering. The new minimum investment is set at $495.44, which corresponds to 44 shares in the offering.

Form Type: 253G2

Filing Date: 2025-04-02

Corporate Action: Ipo

Type: New

Accession Number: 000110465925030828

Filing Summary: Global Health Solutions, Inc., also known as Turn Therapeutics, filed an offering circular on April 2, 2025, to raise funds by offering up to 1,332,149 shares of common stock and an additional 266,430 bonus shares. This offering is pursuant to Regulation A under the SEC rules and aims to fund research and development, working capital, and marketing efforts. The minimum investment required is $990.88 for 88 shares, with the price set at $11.26 per share, excluding underwriting discounts and commissions. StartEngine Primary LLC has been engaged as the underwriter for this offering, and a cash commission of 4.5% will be paid to them on sales. The total projected proceeds from the offering, assuming maximum subscription including bonuses, is approximately $18.15 million. The company emphasizes the speculative nature of these securities with highlighting various risks including regulatory approval, market acceptance, and potential inability to generate sufficient revenue for profitability. They also noted that their common stock is currently not traded on any market, and the rights of investors may be limited due to an irrevocable voting proxy granted to the CEO, affecting their ability to vote on key corporate matters.